The Latin America, Middle East and Africa Precision Diagnostics Market would witness market growth of 20.9% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Precision Diagnostics Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,016.1 million by 2031. The Argentina market is registering a CAGR of 21.6% during (2024 - 2031). Additionally, The UAE market would showcase a CAGR of 19.8% during (2024 - 2031).
Precision diagnostics aid in diagnosing, monitoring, and personalized managing autoimmune diseases and immune deficiencies. They detect specific autoantibodies (such as ANA and anti-dsDNA) to diagnose conditions like lupus and rheumatoid arthritis.
Additionally, they analyze immune cell subsets, cytokines, and inflammatory markers to characterize immune responses and assess disease activity. Multiplex assays for profiling immune biomarkers in autoimmune diseases and predicting treatment responses.
The prevalence of non-communicable diseases such as cardiovascular diseases, diabetes, cancer, and respiratory disorders is rising in Saudi Arabia. This demographic shift towards chronic conditions necessitates accurate and early diagnosis to effectively manage these diseases. According to the International Trade Administration (ITA), non-communicable diseases account for 68 percent of all deaths in Saudi Arabia. Almost 18 percent of the adult population has diabetes, and more than 40 percent are obese.
Free Valuable Insights: The Worldwide Precision Diagnostics Market is Projected to reach USD 55.03 Billion by 2031, at a CAGR of 18.0%
Based on End-use, the market is segmented into Clinical Laboratories, Hospitals, and Others. Based on Type, the market is segmented into Genetic Tests, Esoteric Tests, Direct to Consumer Tests, and Others. Based on Application, the market is segmented into Oncology, Respiratory Diseases, CNS Disorders, Immunology, Skin Diseases, Genetic Diseases, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
By End-use
By Type
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 